Click here to subscribe to our newsletter |
|
|
Articles |
|
|
|
|
Trademarks in the medical sphere: Practice, examination and obstacles for registration in Russia, Ukraine and the CIS
Pharmaceutical industry in Russia, Ukraine and in other CIS countries can be considered one of the most complex industries with a view to the management of intellectual property...
|
|
| |
|
|
Latest Press Releases |
|
|
|
|
Oliver Healthcare Packaging Strengthens Presence in Southeast Asia to Support Growing Customer Demand
Oliver Healthcare is proud to announce an expanded presence in Southeast Asia. With a larger team and a brand-new office & technical development center...
|
|
|
| |
|
|
Spring Bank Pharmaceuticals in Clinical Collaboration With Roche |
Spring Bank Pharmaceuticals Inc. said it has entered into a new clinical collaboration with Roche to explore the co-administration of SB 11285... |
|
|
Sanofi to create new industry leading European company to provide API |
Sanofi plans to create a major leading European company dedicated to the production and marketing to third parties of active pharmaceutical ingredient...
|
|
|
|
|
Key Themes and Technologies Highlighted at Pharmapack Europe 2020
Improving adherence to medication via smarter, patient-centric pharmaceutical packaging and extracting further value from existing medicines and delivery devices are two of the latest key strategies..
|
|
|
|
More News |
|
|
|
|
Turkish Cargo continued its steady growth in 2019
According to the international air cargo information provider WACD's December data , the global air cargo brand Turkish Cargo, which serves 127 countries of the world, grew significantly by achieving...
|
|
|
| |
|
|
Novartis and DNDi to jointly develop a new oral drug to treat visceral leishmaniasis |
Swiss pharma giant Novartis and non-profit research and development organisation Drugs for Neglected Diseases initiative have signed a collabor...
|
|
|
CPhI Japan to be postponed on request of event attendees |
CPhI Japan – organised by Informa Markets announces that the event will be postponed until a new date later in the year after extensive consultancy...
|
|
|
| |
|
|
|
RedHill Biopharma Acquires Rights to Movantik from AstraZeneca
RedHill Biopharm aannounced that it is acquiring the global rights to Movantik excluding Europe, Canada and Israel, from AstraZeneca.
|
|
|